EG 00229 trifluoroacetate

Pricing Availability   Qty
Description: Neuropilin 1 (NRP1) receptor antagonist; inhibits VEGFA binding to NRP1
Chemical Name: N2-[[3-[(2,1,3-Benzothiadiazol-4-ylsulfonyl)amino]-2-thienyl]carbonyl]-L-arginine trifluoroacetate
Purity: ≥98% (HPLC)
Citations (3)
Literature (1)
Pathways (1)

Biological Activity for EG 00229 trifluoroacetate

EG 00229 trifluoroacetate is a neuropilin 1 (NRP1) antagonist; inhibits VEGFA binding to the NRP1 b1 CendR binding pocket. Has no effect on VEGFA binding to VEGFR-1 and VEGFR-2. Reduces VEGFA-induced VEGFR-2 tyrosine phosphorylation in HUVECs. Also attenuates VEGFA-induced HUVEC cell migration and reduces A549 lung carcinoma cell viability in vitro. Inhibits binding of CendR motif in S1 protein of SARS-CoV-2 to NRP1, and reduces efficiency of SARS-CoV-2 infection in Caco-2 cells.

Compound Libraries for EG 00229 trifluoroacetate

EG 00229 trifluoroacetate is also offered as part of the Tocriscreen Antiviral Library. Find out more about compound libraries available from Tocris.

Technical Data for EG 00229 trifluoroacetate

M. Wt 611.59
Formula C17H19N7O5S3.CF3CO2H
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 1210945-69-9
PubChem ID 45142253
Smiles O=S(C1=CC=CC2=NSN=C12)(NC3=C(C(N[C@H](C(O)=O)CCCNC(N)=N)=O)SC=C3)=O.FC(F)(F)C(O)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for EG 00229 trifluoroacetate

Solvent Max Conc. mg/mL Max Conc. mM
DMSO 61.16 100
2eq. NaOH 61.16 100

Preparing Stock Solutions for EG 00229 trifluoroacetate

The following data is based on the product molecular weight 611.59. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.64 mL 8.18 mL 16.35 mL
5 mM 0.33 mL 1.64 mL 3.27 mL
10 mM 0.16 mL 0.82 mL 1.64 mL
50 mM 0.03 mL 0.16 mL 0.33 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Product Datasheets for EG 00229 trifluoroacetate

Certificate of Analysis / Product Datasheet
Select another batch:

References for EG 00229 trifluoroacetate

References are publications that support the biological activity of the product.

Jarvis et al (2010) Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction. J.Med.Chem. 53 2215 PMID: 20151671

Daly et al (2020) Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370 861 PMID: 33082294

If you know of a relevant reference for EG 00229 trifluoroacetate, please let us know.

Keywords: EG 00229 trifluoroacetate, EG 00229 trifluoroacetate supplier, EG00229, trifluoroacetate, EG, 00229, TFA, neuropilin, receptor, antagonists, VEGFA, receptors, nrp1, Vascular, endothelial, growth, factor, SARS-CoV-2, viral, cell, entry, VEGFR, Coronavirus, 6986, Tocris Bioscience

3 Citations for EG 00229 trifluoroacetate

Citations are publications that use Tocris products. Selected citations for EG 00229 trifluoroacetate include:

Daly et al (2020) Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370 861 PMID: 33082294

Curtis A et al (2021) Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry. ACS Chem Neurosci 12 1299-1312 PMID: 33787218

Rajesh et al (2021) SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia. Pain 162 243-252 PMID: 33009246

Do you know of a great paper that uses EG 00229 trifluoroacetate from Tocris? Please let us know.

Reviews for EG 00229 trifluoroacetate

There are currently no reviews for this product. Be the first to review EG 00229 trifluoroacetate and earn rewards!

Have you used EG 00229 trifluoroacetate?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Angiogenesis in Cancer Poster

Angiogenesis in Cancer Poster

This poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.

Pathways for EG 00229 trifluoroacetate

VEGF Signaling Pathway

VEGF Signaling Pathway

VEGF signaling pathway is involved in embryonic vascular development (vasculogenesis) and in the formation of new blood vessel (angiogenesis). It also induces cell migration, proliferation and survival.